Podcasts

The advent of new molecularly targeted treatment strategies for patients with advanced colorectal cancer places anatomic and molecular pathologists as key players in the delivery of care for this large patient population. Specifically, advanced colorectal cancer encompasses patients presenting with Stage IV cancer, or those who experience a cancer recurrence, explains Dr. Joseph Willis in a new CAP.org article, 'Testing of Specimens From Patients With Advanced Colorectal Carcinoma.'

In this CAPcast, Dr. David Gang and Dr. Matthew Foster-two leaders with the CAP’s Federal and State Affairs Committee--discuss their recent trips to Capitol Hill to meet with their legislators on surprise billing.

In this CAPcast interview, Dr. Larsen discusses what CAP members need to know about the pathology of vaping-associated lung injury.

Recently the CAP observed that CMS is citing blood gas labs for not having appropriate personnel during their validation inspections, as Dr. Earle Collum outlines in this CAPcast interview.